TNF’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$202K Hold
10,616
0.07% 119
2024
Q2
$176K Sell
10,616
-1,062
-9% -$15.2K 0.06% 119
2024
Q1
$160K Buy
11,678
+22
+0.2% +$305 0.06% 114
2023
Q4
$157K Sell
11,656
-1,474
-11% -$20.9K 0.06% 111
2023
Q3
$184K Buy
13,130
+24
+0.2% +$307 0.09% 92
2023
Q2
$154K Sell
13,106
-25
-0.2% -$285 0.07% 96
2023
Q1
$150K Buy
13,131
+23
+0.2% +$285 0.07% 96
2022
Q4
$177K Buy
13,108
+22
+0.2% +$281 0.08% 104
2022
Q3
$160K Buy
13,086
+18
+0.1% +$266 0.08% 100
2022
Q2
$193K Sell
13,068
-1,691
-11% -$22.6K 0.09% 111
2022
Q1
$179K Buy
14,759
+20
+0.1% +$274 0.08% 122
2021
Q4
$211K Hold
14,739
0.09% 129
2021
Q3
$199K Buy
+14,739
New +$249K 0.09% 128

Other funds holding SBRA

TNF's SBRA Position: Q3 2024 in Review

TNF held its Sabra Healthcare REIT (SBRA) position steady in Q3 2024 at 10,616 shares worth $202K. The position accounts for 0.07% of the portfolio, ranked #119.

TNF first reported a position in SBRA in Q3 2021 and has held it in 13 quarters since. The position peaked at $211K in Q4 2021. 379 funds tracked by Wall St. Rank hold SBRA as of Q3 2024.

  • TNF held 10,616 shares of Sabra Healthcare REIT worth $202K as of Q3 2024.
  • TNF left its Sabra Healthcare REIT share count unchanged in Q3 2024.
  • Sabra Healthcare REIT made up 0.07% of TNF's portfolio in Q3 2024, its #119 holding.
  • TNF first reported a position in Sabra Healthcare REIT in Q3 2021 and has held it in 13 quarters since.
  • TNF's Sabra Healthcare REIT position peaked at $211K in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2024.

Based on TNF's 13F filing for Q3 2024, filed 25 Oct 2024.